FMC Corporation expands biologicals crop protection platform in Canada


FMC Canada and Novonesis announce a commercial agreement to bring innovative biological solutions to Canadian farmers

PHILADELPHIA, March 12, 2024 /PRNewswire/ --

FMC Corporation Logo. (PRNewsFoto/FMC Corporation)

FMC Corporation (NYSE: FMC), a leading global agricultural sciences company, announced a collaboration in Canada with Novonesis (formerly Novozymes A/S), a leader in plant biosolutions. The agreement is part of FMC's strategic plan to grow its biologicals platform in key markets.

Beginning June 1, 2024, FMC Canada will be the exclusive distributor of Novonesis' leading biosolution products, including proven brands like TagTeam®, Optimize®, JumpStart®, BioniQ®, Cell-Tech®, and Nitragin®, for the 2025 growing season. Additionally, the companies will utilize their respective R&D capabilities to collaborate on the development of novel biological technology for Canadian farmers. 

The partnership will leverage Novonesis' Plant Biosolutions Manufacturing and Research site in Saskatoon, Canada, and FMC's deep market knowledge and expertise in applying biologicals in an integrated approach with synthetic crop protection chemistry and precision agriculture technology. 

"FMC is excited to collaborate with Novonesis to bring Canadian growers effective biological products that complement our biological and synthetic chemistry," said Dr. Bénédicte Flambard, vice president, FMC Plant Health. "As we continue to invest in and expand our biologicals portfolio, we are committed to aligning with partners who enhance our ability to provide growers around the world with science-backed biological solutions that help sustainably manage crops, protect yields and combat resistance."

FMC has launched approximately 40 biological products, including Accudo® biostimulant, Provilar® biofungicide, and Avodigen® seed treatment, in 24 countries over the past five years and is one of the few companies with a fully global presence. The company's geographic footprint, along with its core portfolio, market access and complementary technologies, positions FMC as a top-tier global provider of integrated solutions to help growers sustainably feed the world. 

"Novonesis and FMC share a similar goal of bringing differentiated, sustainable solutions to Canadian farmers," said Devron McLeod, country manager, FMC Canada. "Aligning our technologies and systems to bring new inoculant and biocontrol products to the market will benefit Canadian farmers. This collaboration provides more significant opportunities to bring innovative products to market faster."

"FMC has a strong presence in Canada with consistent growth, a complementary portfolio, and an organization with proven success in launching innovations that deliver value to Canadian farmers," said Jason Ward, Novonesis Plant Biosolutions commercial lead for North America. "This expanded relationship between the two companies demonstrates our shared commitment to providing growers with products they can use to improve yield by increasing nutrient availability and enhancing the plant's natural processes."

The collaboration demonstrates a shared commitment to providing growers with new biological solutions designed to safeguard crop yields while protecting biodiversity and natural resources. FMC's robust pipeline of differentiated biologicals, combined with investments in biologicals and adjacent technologies, enables the continued expansion of its award-winning portfolio. To learn more about Biologicals by FMC, visit

Terms of the commercial agreement were not disclosed.

About FMC

FMC Corporation is a global agricultural sciences company dedicated to helping growers produce food, feed, fiber and fuel for an expanding world population while adapting to a changing environment. FMC's innovative crop protection solutions – including biologicals, crop nutrition, digital and precision agriculture – enable growers, crop advisers and turf and pest management professionals to address their toughest challenges economically while protecting the environment. With approximately 6,600 employees at more than 100 sites worldwide, FMC is committed to discovering new herbicide, insecticide and fungicide active ingredients, product formulations and pioneering technologies that are consistently better for the planet. Visit to learn more and follow us on LinkedIn®

About Novonesis

Novonesis is a global company leading the era of biosolutions. By leveraging the power of microbiology with science, we transform the way the world produces, consumes, and lives. In more than 30 industries, our biosolutions are already creating value for millions of consumers and benefitting the planet. Our 10,000 people worldwide work closely with our partners and customers to transform business with biology. 

Learn more on

FMC, the FMC logo, Accudo, Provilar and Avodigen are trademarks of FMC Corporation or an affiliate. TagTeam, Optimize, JumpStart, BioniQ, Cell-Tech and Nitragin are trademarks of Novozymes A/S.Always read and follow all label directions, restrictions and precautions for use. Products listed here may not be registered for sale or use in all states, countries or jurisdictions.

Statement under the Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995: This release contains statements that are "forward-looking" and provide other than historical information. FMC has identified forward-looking statements by such words or phrases as "will likely result," "is confident that," "expect," "expects," "should," "could," "may," "will continue to," "believe," "believes," "anticipates," "targets" "intends" or similar expressions identifying "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, including the negative of those words and phrases. Such forward-looking statements, which are based on management's current views and assumptions regarding future events, future business conditions and the outlook for the company based on currently available information. These statements involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any results, levels of activity, performance or achievements expressed or implied by any forward-looking statement. These factors include, among other things, the risk factors and other cautionary statements included within FMC's 2023 Form 10-K filed with the SEC as well as other SEC filings and public communications. FMC cautions readers not to place undue reliance on any such forward-looking statements, which speak only as of the date made. Forward-looking statements are qualified in their entirety by the above cautionary statement. FMC undertakes no obligation, and specifically disclaims any duty, to update or revise any forward-looking statements to reflect events or circumstances arising after the date on which they were made, except as otherwise required by law.

Cision View original content to download multimedia:

SOURCE FMC Corporation

In This Story